Search Results 951-960 of 17350 for Break STD Taboo

  1. Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  2. Clinical trials - Gastroenterology and Hepatology

    ... standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to ...

  3. A Study Of Obesity Phenotypes After PCI And CABG - Mayo Clinic

    The purpose of this study is to evaluate clinical outcomes (e.g., mortality, major adverse cardiovascular events [MACE], hospital readmissions) among obese ...

  4. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  5. Gastroenterology and Hepatology - Clinical trials

    DISEASE STATE - Potentially operable or borderline resectable pancreatic adenocarcinoma as assessed by standard CT criteria and histologically confirmed.

  6. Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  7. A Study of the Metabolome and Microbiome Following Bariatric Surgery, and the Effect on Metabolism in Patients with Type 2 Diabetes - Mayo Clinic

    The purpose of this study is to identify changes to the metabolome (range of chemicals produced in the body) and microbiome (intestine microbe environment) that ...

  8. A Study to Evaluate the Effectiveness of Spesolimab to Treat Hidradenitis Suppurativa - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  9. Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...

  10. Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma - Mayo Clinic

    ... standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make ...